1. Greene ND, Copp AJ. Neural tube defects. Annu Rev Neurosci. 2014;37:221-42.
2. Yacob A, Carr CJ, Foote J, Scullen T, Werner C, Mathkour M, et al. The global burden of neural tube defects and disparities in neurosurgical care. World Neurosurg. 2021;149:e803-e820.
3. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol. 2010;686:349-64.
4. Frey L, Hauser WA. Epidemiology of neural tube defects. Epilepsia. 2003;44 Suppl 3:4-13.
5. Chen CP. Chromosomal abnormalities associated with neural tube defects (I): full aneuploidy. Taiwan J Obstet Gynecol. 2007;46:325-35.
6. Chen CP. Syndromes, disorders, and maternal risk factors associated with neural tube defects (II). Taiwan J Obstet Gynecol. 2008;47:10-17.
7. Avagliano, Massa V, George TM, Qureshy S, Bulfamante GP, Finnell RH. Overview on neural tube defects: from development to physical characteristics. Birth Defect Res. 2019;111:1455-67.
8. Copp AJ, Stanier P, Greene ND. Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol. 2013;12:799-810.
9. Harris MJ, Juriloff DM. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol. 2010;88:653-69.
10. Nakatsu T, Uwabe C, Shiota K. Neural tube closure in humans initiates at multiple sites: evidence from human embryos and implications for the pathogenesis of neural tube defects. Anat Embryol (Berl). 2000;201:455-66.
11. O’Rahilly R, Müller F. The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology. 2002;65:162-70.
12. Lew SM, Kothbauer KF. Tethered cord syndrome: an updated review. Pediatr Neurosurg. 2007;43:236-48.
13. Juriloff DM, Harris MJ. Hypothesis: the female excess in cranial neural tube defects reflects an epigenetic drag of the inactivating X chromosome on the molecular mechanisms of neural fold elevation. Birth Defects Res A Clin Mol Teratol. 2012;94:849-55.
14. Agopian, Tinker SC, Lupo PJ, Canfield MA, Mitchell LE; National Birth Defects Prevention Study. Proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol. 2013;97:42-6.
15. Pietrzik K, Bailey L, Shane B. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2010;49:535-48.
16. Copp AJ, Greene ND. Genetics and development of neural tube defects. J Pathol. 2010;220:217-30.
17. Bortolus, Filippini F, Cipriani S, Trevisanuto D, Cavallin F, Zanconato G, et al. Efficacy of 4.0 mg versus 0.4 mg folic acid supplementation on the reproductive outcomes: a randomized controlled trial. Nutrients. 2021;13:4422.
18. Wang L, Chang S, Wang Z, Wang S, Huo J, Ding G, et al. Altered GNAS imprinting due to folic acid deficiency contributes to poor embryo development and may lead to neural tube defects. Oncotarget. 2017;8:110797-110810.
19. Harris MJ, Juriloff DM. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol. 2010;88:653-69.
20. Lei, Fathe K, McCartney D, Zhu H, Yang W, Ross ME, et al. Rare LRP6 variants identified in spina bifida patients. Hum Mutat. 2015;36:342-49.
21. Wlodarczyk BJ, Palacios AM, George TM, Finnell RH. Antiepileptic drugs and pregnancy outcomes. Am J Med Genet. 2012;158A:2071-90.
22. Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology. 2005;16:216-19.
23. Abdel-Shafy HI, Mansour MSM. A review on polycyclic aromatic hydrocarbons: source, environmental impact, effect on human health and remediation. Egypt J Pet. 2016;25:107-23.
24. Li Z, Zhang L, Ye R, Pei L, Liu J, Zheng X, et al. Indoor air pollution from coal combustion and the risk of neural tube defects in a rural population in Shanxi Province, China. Am J Epidemiol. 2011;174:451-58.
25. Langlois PH, Hoyt AT, Lupo PJ, Lawson CC, Waters MA, Desrosiers TA, et al. Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk of neural tube defect-affected pregnancies. Birth Defects Res A Clin Mol Teratol. 2012;94:693-700.
26. Wang B, Jin L, Ren A, Yuan Y, Liu J, Li Z, et al. Levels of polycyclic aromatic hydrocarbons in maternal serum and risk of neural tube defects in offspring. Environ Sci Technol. 2015;49:588-96.
27. Patel AB, Shaikh S, Jain KR, Desai C, Madamwar D. Polycyclic aromatic hydrocarbons: sources, toxicity, and remediation approaches. Front Microbiol. 2020;11:562813.
28. Amitai Y, Koren G. High risk for neural tube defects; the role of arsenic in drinking water and rice in Asia. Med Hypotheses. 2018;119:88-90.
29. Wlodarczyk BJ, Cabrera RM, Hill DS, Bozinov D, Zhu H, Finnell RH. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos. Neurotoxicology. 2006;27:547-57.
30. Mazumdar M. Does arsenic increase the risk of neural tube defects among a highly exposed population? A new case-control study in Bangladesh. Birth Defects Res. 2017;109:92-8.
31. Kalra, Dewan P, Batra P, Sharma T, Tyagi V, Banerjee BD. Organochlorine pesticide exposure in mothers and neural tube defects in offsprings. Reprod Toxicol. 2016;66:56-60.
32. Brender JD, Felkner M, Suarez L, Canfield MA, Henry JP. Maternal pesticide exposure and neural tube defects in Mexican Americans. Ann Epidemiol. 2010;20:16-22.
33. Baldacci S, Gorini F, Santoro M, Pierini A, Minichilli F, Bianchi F. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence. Epidemiol Prev. 2018;42(3-4 Suppl 1):1-34.
34. Suarez L, Felkner M, Brender JD, Canfield M, Zhu H, Hendricks KA. Neural tube defects on the Texas-Mexico border: what we’ve learned in the 20 years since the Brownsville Cluster. Birth Defects Res A Clin Mol Teratol. 2012;94:882-92.
35. Shaw GM, Wasserman CR, O’Malley CD, Nelson V, Jackson RJ. Maternal pesticide exposure from multiple sources and selected congenital anomalies. Epidemiology. 1999;10:60-6.
36. Balarajan R, McDowall M. Congenital malformations and agricultural workers. Lancet. 1983;1:1112-13.
37. Zhang J, Chen FZ, Gao Q, Sun JH, Tian GP, Gao YM. Hyperthermia induces upregulation of connexin43 in the golden hamster neural tube. Birth Defects Res A Clin Mol Teratol. 2012;94:16-21.
38. Harvey MA, McRorie MM, Smith DW. Suggested limits to the use of the hot tub and sauna by pregnant women. Can Med Assoc J. 1981;125:50-3.
39. Lundberg YW, Wing MJ, Xiong W, Zhao J, Finnell RH. Genetic dissection of hyperthermia-induced neural tube defects in mice. Birth Defects Res A Clin Mol Teratol. 2003;67:409-13.
40. Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2009;163:978-85.
41. Gilboa SM, Broussard CS, Devine OJ, Duwe KN, Flak AL, Boulet SL, et al. Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States. Am J Med Genet C Semin Med Genet. 2011;157:234-46.
42. Interrante JD, Ailes EC, Lind JN, Anderka M, Feldkamp ML, Werler MM, et al. Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011. Ann Epidemiol. 2017;27:645-653.e2.
43. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-37.
44. Sudiwala, Palmer A, Massa V, Burns AJ, Dunlevy LPE, de Castro SCP, et al. Cellular mechanisms underlying Pax3-related neural tube defects and their prevention by folic acid. Dis Model Mech. 2019;12:dmm042234.
45. Barbera JP, Rodriguez TA, Greene ND, Weninger WJ, Simeone A, Copp AJ, et al. Folic acid prevents exencephaly in Cited2 deficient mice. Hum Mol Genet. 2002;11:283-93.
46. van Straaten HW, Copp AJ. Curly tail: a 50-year history of the mouse spina bifida model. Anat Embryol (Berl). 2001;203:225-37.
47. De Castro SC, Leung KY, Savery D, Burren K, Rozen R, Copp AJ, et al. Neural tube defects induced by folate deficiency in mutant curly tail (Grhl3) embryos are associated with alteration in folate one-carbon metabolism but are unlikely to result from diminished methylation. Birth Defects Res A Clin Mol Teratol. 2010;88:612-18.
48. Greene ND, Leung KY, Copp AJ. Inositol, neural tube closure and the prevention of neural tube defects. Birth Defects Res. 2017;109:68-80.
49. Cockroft DL, Brook FA, Copp AJ. Inositol deficiency increases the susceptibility to neural tube defects of genetically predisposed (curly tail) mouse embryos in vitro. Teratology. 1992;45:223-32.
50. Russo M, Forte G, Montanino Oliva M, Laganà AS, Unfer V. Melatonin and myo-inositol: supporting reproduction from the oocyte to birth. Int J Mol Sci. 2021;22:8433.
51. D’Souza SW, Copp AJ, Greene NDE, Glazier JD. Maternal inositol status and neural tube defects: a role for the human yolk sac in embryonic inositol delivery? Adv Nutr. 2021;12:212-22.
52. Dinicola S, Unfer V, Facchinetti F, Soulage CO, Greene ND, Bizzarri M, et al. Inositols: from established knowledge to novel approaches. Int J Mol Sci. 2021;22:10575.
53. Rose NC, Mennuti MT. Fetal neural tube defects: diagnosis, management, and treatment. Carlisle (UK): The Foundation for The Global Library of Women’s Medicine; 2009.
54. Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15:36-45.
55. Gupta DK, Sharma S, Venugopal P, Kumar L, Mohanty S, Dattagupta S. Stem cells as a therapeutic modality in pediatric malformations. Transplant Proc. 2007;39:700-2.
56. Mitrecic, Nicaise C, Klimaschewski L, Gajovic S, Bohl D, Pochet R. Genetically modified stem cells for the treatment of neurological diseases. Front Biosci (Elite Ed). 2012;4:1170-81.
57. Isaković J, Šimunić I, Jagečić D, Hribljan V, Mitrečić D. Overview of neural tube defects: gene-environment interactions, preventative approaches and future perspectives. Biomedicines. 2022;10:965.
58. Godzik, Ravindra VM, Ray WZ, Eskandari R, Dailey AT. Primary repair of open neural tube defect in adulthood: case example and review of management strategies. Spine J. 2015;15:e57-e63.
59. Rossi A, Cama A, Tortori-Donati P. Spinal dysraphism: a review of neurological features. Paediatr Neuroradiol. 2000;42:471-91.
60. Youmans JR, editor. Neurological surgery. 2nd ed. Philadelphia: WB Saunders; 1982. p. 1.